Ablation of liver

BAs, bile acids Colon DSS, dextran sodium sulfate FITC, fluorescein isothiocyanate Farnesoid X receptor Fgfr4, fibroblast growth factor receptor 4 Fxr, farnesoid X receptor Fxr-intKO, intestine-specific Fxr knockout Fxr-livKO, liver-specific Fxr knockout Fxr-totKO, whole body Fxr knockout GO, Gene Ontology Gut microbiome HID, high-iron diamine IBD, inflammatory bowel disease Intestine-specific Fxr-KO mouse KEGG, Kyoto Encyclopedia of Genes and Genomes Liver-specific Fxr-KO mouse Liver–gut axis Mucus layer RT qPCR, real-time quantitative PCR fpkm, fragments per kilobase of transcript per million mapped reads

Journal

JHEP reports : innovation in hepatology
ISSN: 2589-5559
Titre abrégé: JHEP Rep
Pays: Netherlands
ID NLM: 101761237

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 01 06 2021
revised: 16 07 2021
accepted: 22 07 2021
entrez: 4 10 2021
pubmed: 5 10 2021
medline: 5 10 2021
Statut: epublish

Résumé

The interorgan crosstalk between the liver and the intestine has been the focus of intense research. Key in this crosstalk are bile acids, which are secreted from the liver into the intestine, interact with the microbiome, and upon absorption reach back to the liver. The bile acid-activated farnesoid X receptor ( Fxr floxed/floxed mice were crossed with cre-expressing mice to yield Despite relatively small changes in biliary bile acid concentration and composition, more genes were differentially expressed in the colons of Targeting of This study shows that the communication of the liver to the intestine is crucial for intestinal health. Bile acids are key players in this liver-to-gut communication, and when

Sections du résumé

BACKGROUND & AIMS OBJECTIVE
The interorgan crosstalk between the liver and the intestine has been the focus of intense research. Key in this crosstalk are bile acids, which are secreted from the liver into the intestine, interact with the microbiome, and upon absorption reach back to the liver. The bile acid-activated farnesoid X receptor (
METHODS METHODS
Fxr floxed/floxed mice were crossed with cre-expressing mice to yield
RESULTS RESULTS
Despite relatively small changes in biliary bile acid concentration and composition, more genes were differentially expressed in the colons of
CONCLUSIONS CONCLUSIONS
Targeting of
LAY SUMMARY BACKGROUND
This study shows that the communication of the liver to the intestine is crucial for intestinal health. Bile acids are key players in this liver-to-gut communication, and when

Identifiants

pubmed: 34604725
doi: 10.1016/j.jhepr.2021.100344
pii: S2589-5559(21)00120-8
pmc: PMC8463863
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100344

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

Authors declare no conflict of interest, except for RP, CEO at TES Pharma; CC, employed by TESS Pharma; and SY, currently working at Janssen Pharmaceuticals. Please refer to the accompanying ICMJE disclosure forms for further details.

Références

Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):588-600
pubmed: 24912389
Nat Commun. 2019 Feb 22;10(1):905
pubmed: 30796211
Cell Metab. 2005 Oct;2(4):217-25
pubmed: 16213224
Liver Int. 2015 Apr;35(4):1133-1144
pubmed: 25156247
Cell Host Microbe. 2018 Jan 10;23(1):27-40.e7
pubmed: 29276171
Gastroenterology. 2020 May;158(7):1984-1998.e3
pubmed: 32061596
PLoS One. 2011;6(6):e20749
pubmed: 21694778
Cell Metab. 2011 Jun 8;13(6):729-38
pubmed: 21641554
Trends Mol Med. 2016 Mar;22(3):190-199
pubmed: 26852376
Sci Rep. 2015 Mar 19;5:9253
pubmed: 25787310
Int J Oncol. 2019 Mar;54(3):879-892
pubmed: 30747230
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3920-5
pubmed: 16473946
J Lipid Res. 2007 Dec;48(12):2664-72
pubmed: 17720959
Sci Rep. 2019 Dec 11;9(1):18880
pubmed: 31827191
Front Genet. 2017 Aug 29;8:111
pubmed: 28912798
Cell. 2014 Feb 27;156(5):1045-59
pubmed: 24581500
Digestion. 2016;93(1):59-65
pubmed: 26789999
Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G151-8
pubmed: 19815629
Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):45-59
pubmed: 28986309
Nature. 2012 Jul 5;487(7405):104-8
pubmed: 22722865
Nature. 2020 Jan;577(7790):410-415
pubmed: 31875848
Oncogene. 2010 May 20;29(20):2893-904
pubmed: 20348949
Mucosal Immunol. 2014 Jul;7(4):939-47
pubmed: 24345802
Hepatol Commun. 2018 Oct 01;2(12):1567-1582
pubmed: 30556042
Front Med (Lausanne). 2020 Sep 11;7:544
pubmed: 33015098
Gut. 2011 Apr;60(4):463-72
pubmed: 21242261
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20858-63
pubmed: 19075245
Am J Physiol Gastrointest Liver Physiol. 2012 Feb 15;302(4):G430-8
pubmed: 22159279
Front Genet. 2015 Mar 19;6:81
pubmed: 25852737
Gastroenterology. 2011 Nov;141(5):1773-81
pubmed: 21839040
Science. 2011 Mar 25;331(6024):1621-4
pubmed: 21436455
Science. 2006 Aug 25;313(5790):1126-30
pubmed: 16931762
Front Cell Infect Microbiol. 2019 Apr 24;9:117
pubmed: 31069176
Clin Sci (Lond). 1992 Nov;83(5):623-6
pubmed: 1335401
Microorganisms. 2018 Aug 02;6(3):
pubmed: 30072673
Endocrinology. 2002 May;143(5):1741-7
pubmed: 11956156
Physiol Rev. 2018 Oct 1;98(4):1983-2023
pubmed: 30067158

Auteurs

Noortje Ijssennagger (N)

Department of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Kristel S van Rooijen (KS)

Department of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Stefanía Magnúsdóttir (S)

Department of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

José M Ramos Pittol (JM)

Department of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Institute of Biochemistry, University of Innsbruck, Innsbruck, Austria.

Ellen C L Willemsen (ECL)

Department of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Marcel R de Zoete (MR)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Matthijs J D Baars (MJD)

Department of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Paul B Stege (PB)

Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Carolina Colliva (C)

TES Pharma S.r.l., Perugia, Italy.

Roberto Pellicciari (R)

TES Pharma S.r.l., Perugia, Italy.

Sameh A Youssef (SA)

Non-Clinical Safety, Department of Pathology, Janssen Pharmaceutica Research and Development, Beerse, Belgium.

Alain de Bruin (A)

Departments of Pediatrics and Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.

Yvonne Vercoulen (Y)

Department of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Folkert Kuipers (F)

Departments of Pediatrics and Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Saskia W C van Mil (SWC)

Department of Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Classifications MeSH